Physician profile
Joseph A Murphy
NPI 1730158924
$4,525.76
in general payments reported to CMS, 2019-2025
26 companies · $619 in 2025
The $619 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $364 · 2021: $603 · 2022: $802 · 2023: $905 · 2024: $609 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $718.20 | 2019-2023 | Iluvien |
| Genentech USA, INC. | $582.24 | 2019-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $516.56 | 2020-2025 | Eylea Hd, Eylea |
| Novartis Pharmaceuticals Corporation | $406.87 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $359.35 | 2022-2025 | Syfovre |
| Eyepoint US, INC. | $304.64 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $232.61 | 2019-2022 | |
| Astellas Pharma US INC | $200.33 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $128.55 | 2022-2025 | Xipere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2021 | |
| Abbvie INC. | $115.84 | 2022-2024 | |
| Harrow Eye, LLC | $115.53 | 2024-2025 | Iheezo, Triesence |
| Ani Pharmaceuticals, INC. | $114.56 | 2025 | Yutiq, Iluvien |
| Sandoz INC. | $92.42 | 2024-2025 | Cimerli |
| Coherus Oncology, INC. | $92.06 | 2022-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $85.68 | 2024-2025 | Pavblu |
| Eyevance Pharmaceuticals LLC | $64.53 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $55.38 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.51 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $39.00 | 2020 | |
| Thea Pharma INC. | $29.87 | 2023 | Iyuzeh |
| Biogen, INC. | $23.35 | 2023 | |
| Spark Therapeutics, INC. | $21.13 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $21.04 | 2019 | |
| Alcon Vision LLC | $20.11 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.